z-logo
open-access-imgOpen Access
Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia
Author(s) -
Ying Wang,
Zhichao Du,
Yongdong Chen,
Yugang Liu,
Zhitang Yang
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000024883
Subject(s) - medicine , ceftazidime , febrile neutropenia , meropenem , amikacin , neutropenia , intensive care medicine , empirical treatment , oncology , antibiotics , chemotherapy , microbiology and biotechnology , antibiotic resistance , genetics , bacteria , pseudomonas aeruginosa , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here